PlusCBD™ Oil Roll-On publish at 945 Kroger shops in 17 U.S. States
VEGAS, June 12, 2019 (WORLD NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent provider and maker of hemp CBD items, is very happy to announce further expansion of the industry-dominating PlusCBD™ Oil brand name aided by the Kroger Co. (NYSE:KR).
The Company’s expanded distribution that is retail the launch of CV Sciences’ new PlusCBD Oil™ Roll-Ons in 945 Kroger shops across several of its retail ads, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and Smiths places in 17 U.S. states. PlusCBD™ Oil Roll-On, for sale in 200mg CBD and further Strength 500mg formulations, is infused with concentrated CBD from agricultural hemp plant components, warming camphor and cooling menthol. Created using its Gold Formula focused complete range hemp extract, the Roll-Ons offer high strength help in an easy-to-use application. The Company’s best-selling PlusCBD™ Oil Extra Strength and Original Balms can also be found at the participating Kroger places. To generally meet customer expectations of clean components, all PlusCBD™ Oil topical services and products contain no phthalates, sulfates or parabens as they are made without artificial dyes or scents.
As talked about in the Company’s quarter that is first profits turn to May 8, 2019, CV Sciences’ recent circulation gains consist of accessibility to PlusCBD™ Oil Extra Strength Balm in a short launch at CVS Pharmacy shops. By the addition of 945 Kroger places and new circulation into other leading Food, Drug and Mass (FDM) stores, at the time of June 12, 2019, PlusCBD™ Oil branded items are for sale in 4,591 stores, up from 3,308 shops at the time of March 31, 2019, a rise of 38.7% on the previous 8 weeks.
“We are pleased to partner with Kroger and launch our Roll-On that is new topical we carry on our fast expansion in to the FDM channel,” said Joseph Dowling, ceo. “Kroger, CVS Pharmacy, and other leading nationwide retailers are keenly alert to the increased customer need for hemp-based CBD items and they’re partnering with CV Sciences due to our unwavering dedication to security and quality. We have been at the start of everything we think is likely to be acceptance that is broad of products across national FDM reports so we look ahead to our continued development once we increase store count and SKUs with this retail partners.”
PlusCBD™ Oil Extra Strength cbd oil Balm ranks #1 in product sales both in the U.S. that is total Natural and Total U.S. MULO (Multi Outlet) over the past 52 months* among CBD services and products within Topical Analgesics, based on SPINS and IRI information, correspondingly. Brightfield Group, a prominent predictive analytics and general market trends firm for the CBD market, expects $1.3 billion in product sales of CBD topicals in 2019, by having an ingredient yearly development price of 169% from 2018 – 2022.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) runs two distinct business sections: a customer item unit centered on production, advertising and selling plant-based CBD items to a selection of market sectors; and a medication development unit focused on developing and commercializing CBD-based novel therapeutics using CBD. The Company’s PlusCBD™ Oil could be the brand that is top-selling of CBD available on the market, according to SPINS, the key provider of syndicated data and insights for the normal, natural and specialty services and products industry. CV Sciences, Inc. has primary offices and facilities in north park, Ca and Las Vegas, Nevada. More information can be obtained from OTCMarkets.com or by visiting www.cvsciences.com.
This news release may include specific statements that are forward-looking information, as defined inside the concept of Section 27A for the Securities Act of 1933 and Section 21E associated with the Securities Exchange Act of 1934, and it is susceptible to the secure Harbor produced by those parts. This product contains statements about anticipated future occasions and/or monetary outcomes which can be forward-looking in nature and susceptible to dangers and uncertainties. Such statements that are forward-looking meaning incorporate dangers, uncertainties.